| 19.05.2021 07:00 | DEST | Notice to Register for 2021 AGM | RNS |
| 06.05.2021 10:00 | DEST | Conference Attendance for May 2021 | Reach |
| 04.05.2021 07:00 | DEST | Posting of Annual Report and Notice of AGM | RNS |
| 30.04.2021 07:00 | DEST | Director Dealing | RNS |
| 23.04.2021 07:00 | DEST | Director Dealing | RNS |
| 15.04.2021 08:00 | DEST | FY 2020 Investor Presentation | Reach |
| 14.04.2021 07:00 | DEST | Final Results | RNS |
| 29.03.2021 12:45 | DEST | Exercise of Options and Total Voting Rights | RNS |
| 29.03.2021 12:00 | DEST | Destiny Pharma to Join Equity Development Webinar | Reach |
| 29.03.2021 11:06 | DEST | Second Price Monitoring Extn | RNS |
| 29.03.2021 11:00 | DEST | Price Monitoring Extension | RNS |
| 29.03.2021 10:15 | DEST | Exercise of Options and Total Voting Rights | RNS |
| 29.03.2021 09:06 | DEST | Second Price Monitoring Extn | RNS |
| 29.03.2021 09:00 | DEST | Price Monitoring Extension | RNS |
| 29.03.2021 07:00 | DEST | Destiny Pharma Reports Positive Phase 2b Results | RNS |
| 16.03.2021 07:00 | DEST | Notice of Results | RNS |
| 15.03.2021 07:00 | DEST | Destiny Pharma Announces Agreement with NIAID | Reach |
| 10.03.2021 14:15 | DEST | Exercise of Options and Total Voting Rights | RNS |
| 10.03.2021 07:00 | DEST | Destiny Pharma CSO Joins UKRI COVID-19 Taskforce | Reach |
| 10.02.2021 14:05 | DEST | Second Price Monitoring Extn | RNS |
| 10.02.2021 14:00 | DEST | Price Monitoring Extension | RNS |
| 03.02.2021 07:00 | DEST | Brazilian Patent Granted for XF-73 nasal gel | Reach |
| 02.02.2021 07:05 | DEST | Destiny Pharma to join panel discussion at LSX | Reach |
| 02.02.2021 07:00 | DEST | Destiny Pharma Appoints Professor Mark Wilcox | Reach |
| 21.01.2021 16:41 | DEST | Second Price Monitoring Extn | RNS |
| 21.01.2021 16:35 | DEST | Price Monitoring Extension | RNS |
| 21.01.2021 16:31 | DEST | Grant of Share Options | RNS |
| 21.01.2021 08:28 | DEST | Destiny Pharma Investor Presentation | Reach |
| 14.01.2021 11:05 | DEST | Second Price Monitoring Extn | RNS |
| 14.01.2021 11:00 | DEST | Price Monitoring Extension | RNS |
| 07.01.2021 11:05 | DEST | Second Price Monitoring Extn | RNS |
| 07.01.2021 11:00 | DEST | Price Monitoring Extension | RNS |
| 07.01.2021 07:00 | DEST | Destiny Pharma: Directors Dealings | RNS |
| 06.01.2021 08:00 | DEST | Destiny Pharma Appoints Stephanie Bewick as CBO | Reach |
| 05.01.2021 07:00 | DEST | Phase 2b trial of XF-73 completes recruitment | RNS |
